Net Cash Provided by (Used in) Operating Activities |
-42.5K |
USD |
-12.4% |
Q3 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
0 |
USD |
-100% |
Q3 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q3 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
250M |
shares |
0% |
Q3 2024 |
Q1 2025 |
Common Stock, Shares, Issued |
105M |
shares |
+18.3% |
Q3 2024 |
Q1 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-42.5K |
USD |
-786% |
Q3 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
20.9K |
USD |
-60.9% |
Q4 2022 |
Q2 2023 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
1.28K |
USD |
0% |
Q3 2024 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
154K |
USD |
+3.16% |
Q2 2024 |
FY 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
154K |
USD |
+3.16% |
Q2 2024 |
FY 2024 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2024 |
Q1 2025 |
Preferred Stock, Shares Authorized |
50M |
shares |
0% |
Q3 2024 |
Q1 2025 |
Additional Paid in Capital |
3.23M |
USD |
+8.24% |
Q3 2024 |
Q1 2025 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q1 2022 |
Q3 2022 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q2 2024 |
FY 2024 |
Interest Expense |
11.4K |
USD |
+35% |
Q3 2024 |
Q1 2025 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q1 2025 |